CS
MEDP icon

Candriam SCA’s Medpace MEDP Stock Holding History

Candriam SCA’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7M Sell
25,876
-77,473
-75% -$35.8M 0.06% 247
2026
Q1 		$49.6M Buy
103,349
+64,314
+165% +$32.9M 0.26% 89
2025
Q4 		$21.9M Buy
39,035
+21,814
+127% +$12.4M 0.11% 181
2025
Q3 		$8.85M Sell
17,221
-34,434
-67% -$15M 0.05% 289
2025
Q2 		$16.2M Sell
51,655
-8,662
-14% -$2.6M 0.09% 194
2025
Q1 		$18.4M Sell
60,317
-875
-1% -$294K 0.12% 169
2024
Q4 		$20.3M Sell
61,192
-22,089
-27% -$7.49M 0.12% 164
2024
Q3 		$27.8M Buy
83,281
+8,720
+12% +$3.31M 0.16% 135
2024
Q2 		$30.7M Buy
74,561
+54,255
+267% +$21.5M 0.19% 119
2024
Q1 		$8.21M Buy
+20,306
New +$7.14M 0.05% 276
2023
Q4 		– Sell
-5,750
Closed -$1.39M – 718
2023
Q3 		$1.39M Sell
5,750
-4,144
-42% -$1.06M 0.01% 504
2023
Q2 		$2.38M Buy
9,894
+6,157
+165% +$1.28M 0.02% 470
2023
Q1 		$647K Buy
+3,737
New +$773K ﹤0.01% 743
2022
Q4 		– Sell
-21,729
Closed -$3.42M – 879
2022
Q3 		$3.42M Buy
+21,729
New +$3.47M 0.02% 469

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Candriam SCA's MEDP Position: Q2 2026 in Review

Candriam SCA reduced its Medpace (MEDP) stake by 75% in Q2 2026, selling an estimated $35.8M and leaving 25,876 shares worth $13.7M. The position accounts for 0.06% of the portfolio, ranked #247.

Candriam SCA first reported a position in MEDP in Q3 2022 and has held it in 14 quarters since. The position peaked at $49.6M in Q1 2026. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Candriam SCA held 25,876 shares of Medpace worth $13.7M as of Q2 2026.
  • Candriam SCA sold 77,473 Medpace shares in Q2 2026, an estimated $35.8M.
  • Medpace made up 0.06% of Candriam SCA's portfolio in Q2 2026, its #247 holding.
  • Candriam SCA first reported a position in Medpace in Q3 2022 and has held it in 14 quarters since.
  • Candriam SCA's Medpace position peaked at $49.6M in Q1 2026.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.